Success Stories: EB-1A Approved for Interventional Cardiologist in Virginia in the Field of Clinical Medicine
Client’s Testimonial:
Thank you so much for the great news. You guys are awesome.
On August 17th, 2015, We Received another EB1-A (Alien of Extraordinary Ability) Approval for an Interventional Cardiologist in the Field of Clinical Medicine (Approval Notice)
Position at the Time of Case Filing: Interventional Cardiologist
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Virginia
Approval Notice Date: August 17th, 2015
Processing Time: 1 Year, 3 Months, 24 Days (Including RFE Response Time)
In this case, the client that we had the opportunity to work with was an interventional cardiologist from India in the field of clinical medicine. Specifically, our client’s specialized research has focused on DNA transfer in Mycobacteria, assessment of right ventricle function, and rare causes of myocardial infarction. His work had resulted in 4 peer-reviewed scientific articles and 2 presentations at national conferences; at the time that his case was filed, his publications had been cited at least 122 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed numerous manuscripts for 2 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client’s] influence on the field of medical research is wide, inspiring further research projects at esteemed institutions around the globe. It is the originality and innovation inherent in [client’s] work that separates it from the work of his peers and recommends it for further research opportunities.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of clinical medicine, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 1 year, 3 months and 24 days.